Abstract
In the current review article, evidences on radical surgery for gastric cancer reported in the literature are highlighted. The authors conclude that extended lymphadenectomy offers a statistically significant survival benefit. This benefit is only evident if the operative mortality is less than 2%, as obtained in centers of excellence with a high-volume experience of resection of gastric cancer. Lymphadenectomy should no longer be considered only as a tool for cancer-staging, but also as a beneficial therapeutic measure.
Key Words:
Additional information
Notes on contributors
Y. Kodera
Department of Surgery II Nagoya University School of Medicine 65 Tsurumai Showa, Nagoya Aichi 466–8550, Japan Tel.: +81-52-744-2250 Fax: +81-52-744-2255 E-mail: [email protected]